Errors occurred in the author list and acknowledgements of the following paper: ‘Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus?’ Tortajada C, Martínez-Lacasa J, Sánchez F, Jiménez-Fuentes A, De Souza M L, García J F, Martínez J A, Caylà J A, Int J Tuberc Lung Dis 2005; 9(3): 276–281 Acknowledgements were omitted in the article entitled ‘Tuberculosis education in an endemic setting: application of participatory methods to video development in The Gambia.’ Martin M, Brookes L, Cham A, Sowe D M, Khan S, Thomas D R, Hill P C, Int J Tuberc Lung Dis 2005; 9(5): 550–555
Document Type: Erratum
Publication date: June 1, 2005
More about this publication?
The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.
Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website